ProMedica Health System

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, ProMedica Health System sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials 2 currently recruiting 10 completed top decile by trial count

ProMedica Health System: 12 sponsored US clinical trials, 2 recruiting.

ProMedica Health System sponsors 12 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 10 completed. 3 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Ischemic Stroke, with 2 trials.

Top-decile sponsor footprint

ProMedica Health System ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

10 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

12 total, page 1 of 1

RECRUITING Phase 3

Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis

NCT07356284
RECRUITING Phase 2

Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial

NCT06949228
COMPLETED Phase 2

Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial

NCT05172934
COMPLETED Phase 3

Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke

NCT05175547
COMPLETED NA

Tap Block vs Conventional Pain Medication for Patients Undergoing Robotic Sacrocolpopexy

NCT04440475
COMPLETED Phase 4

Ethyl Chloride for NPWT

NCT04635696
COMPLETED NA

Satisfaction Following Cesarean Section

NCT03355248
COMPLETED

Use of NAVA-catheter Positioning Screen to Identify Different Cardiac Arrhythmias

NCT02040675
COMPLETED NA

Evaluating Advantages of Prevena After Hip and Knee Arthroplasty

NCT01854138
COMPLETED NA

Comparing NAVA Levels in Intubated and Recently Extubated Neonates to Determine Optimal Non-invasive Ventilatory Support

NCT02048280
COMPLETED NA

Efficacy of Energy Shots and Caffeine for Energy and Wakefulness Levels

NCT01755299
COMPLETED NA

Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus

NCT00985361

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 2
Phase 4 1

Therapeutic Areas

Ischemic Stroke 2
Other Specified Respiratory Problems in Fetus or Neonate 1
Infection of Total Hip Joint Prosthesis 1
Cardiac Arrhythmia 1
Acute Disease 1

What is open in the ProMedica Health System pipeline

2 recruiting of 12 indexed (17% open); 10 completed (83%).

Phase mix: 3 late (III/IV) vs 2 early (I/II) (balanced across stages).

Top condition: Ischemic Stroke (2 trials), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

ProMedica Health System: open-pipeline peers nationwide

Peers matched on 12 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

ProMedica Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 468101214 0%5%10%15%20% Total trials Recruiting share ProMedica Health SystemAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.AngiodynamicsAdageneAgendiaAkamis BioAnthos Therapeutics
ProMedica Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

ProMedica Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this ProMedica Health System page

12 registered trials is a research-attention snapshot, not an endorsement of ProMedica Health System or any single study.

  • 2 of ProMedica Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Ischemic Stroke is the condition ProMedica Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Ischemic Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

ProMedica Health System pipeline card: 12 registered trials from official public datasets.Report a data error.